Article
Integrative proteomic characterization of human lung adenocarcinoma with KRAS G12 mutations reveals molecular pathogenesis.
Journal of advanced research - 1 Jun 2026
Shi Xinyu, Hu Liling, Huang Yongshi, Zhang Mei-Fang, Ying Xingfeng, Yuan Xiaoyi, Wen Nengqiao, Lu Jiangli, Zou Hanchen, Tan Xiaohui, He Qing-Yu, Wang Fang, Yang Hong, Zhang Chris Zhiyi
Abstract excerpt
INTRODUCTION: Integrated proteogenomic studies of lung adenocarcinoma (LUAD) have provided unique insights with potential clinical effects. Comprehensive proteomic analyses are needed to better understand the molecular landscape of LUAD with KRAS G12 mutations. OBJECTIVES: This study aims to characterize the proteogenomic profile of LUAD with KRAS G12 mutation variants. METHODS: We performed next-generation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
